Occupe actuellement des postes chez Stemline Therapeutics Inc and Beyond Air Inc
Position | Company | Period |
---|---|---|
Independent Director | Stemline Therapeutics Inc | 1 janvier 2009 - |
Independent Director | Beyond Air Inc | 13 janvier 2017 - |
Chief Executive Officer, Director | Urogen Pharma Ltd | 1 octobre 2015 - 3 janvier 2019 |
Executive Chairman of the Board | Beyond Air Inc | 1 août 2015 - 13 janvier 2017 |
Chief Executive Officer, Director | Keryx Biopharmaceuticals Inc | 16 juin 2009 - 30 avril 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-19 | 2024-03-18 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
5 000
+0.2%
10,2951 450 USD |
5 000 +0.2% | 10,29 | 51 450 USD | |
2023-10-12 | 2023-10-10 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
640
+0.0%
11,087 091 USD |
640 +0.0% | 11,08 | 7 091 USD | |
2023-10-10 | 2023-10-09 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
830
+0.0%
11,199 288 USD |
830 +0.0% | 11,19 | 9 288 USD | |
2023-10-10 | 2023-10-06 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
250
+0.0%
11,272 818 USD |
250 +0.0% | 11,27 | 2 818 USD | |
2023-08-11 | 2023-08-11 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
180
+0.0%
14,662 639 USD |
180 +0.0% | 14,66 | 2 639 USD | |
2023-08-11 | 2023-08-08 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
120
+0.0%
14,831 780 USD |
120 +0.0% | 14,83 | 1 780 USD | |
2023-07-24 | 2023-07-21 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
225
+0.0%
14,853 341 USD |
225 +0.0% | 14,85 | 3 341 USD | |
2023-07-24 | 2023-07-20 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
110
+0.0%
15,061 657 USD |
110 +0.0% | 15,06 | 1 657 USD | |
2023-07-20 | 2023-07-19 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200
+0.0%
14,332 866 USD |
200 +0.0% | 14,33 | 2 866 USD | |
2023-07-18 | 2023-07-14 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
150
+0.0%
15,032 255 USD |
150 +0.0% | 15,03 | 2 255 USD | |
2023-07-18 | 2023-07-07 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
110
+0.0%
16,191 781 USD |
110 +0.0% | 16,19 | 1 781 USD | |
2023-07-07 | 2023-07-06 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
320
+0.0%
14,884 762 USD |
320 +0.0% | 14,88 | 4 762 USD | |
2023-06-27 | 2023-06-26 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
750
+0.0%
16,5012 375 USD |
750 +0.0% | 16,50 | 12 375 USD | |
2023-06-22 | 2023-06-21 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
17,888 940 USD |
500 +0.0% | 17,88 | 8 940 USD | |
2023-06-08 | 2023-06-08 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
120
+0.0%
17,532 104 USD |
120 +0.0% | 17,53 | 2 104 USD | |
2023-06-08 | 2023-06-07 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
230
+0.0%
17,414 004 USD |
230 +0.0% | 17,41 | 4 004 USD | |
2023-06-01 | 2023-05-31 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
330
+0.0%
17,285 702 USD |
330 +0.0% | 17,28 | 5 702 USD | |
2023-05-26 | 2023-05-24 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200
+0.0%
17,493 498 USD |
200 +0.0% | 17,49 | 3 498 USD | |
2023-05-18 | 2023-05-16 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
320
+0.0%
17,035 448 USD |
320 +0.0% | 17,03 | 5 448 USD | |
2023-03-27 | 2023-03-23 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
230
+0.0%
12,132 790 USD |
230 +0.0% | 12,13 | 2 790 USD | |
2023-03-23 | 2023-03-21 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
480
+0.0%
12,085 798 USD |
480 +0.0% | 12,08 | 5 798 USD | |
2023-03-21 | 2023-03-20 |
Beyond Air Inc
(XAIR)
|
A Achat |
2 300
+1.6%
6,4814 904 USD |
2 300 +1.6% | 6,48 | 14 904 USD | |
2023-03-16 | 2023-03-15 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
480
+0.0%
10,915 237 USD |
480 +0.0% | 10,91 | 5 237 USD | |
2023-03-16 | 2023-03-14 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 680
+0.1%
10,8518 228 USD |
1 680 +0.1% | 10,85 | 18 228 USD | |
2022-11-30 | 2022-11-30 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
150
+0.0%
7,451 118 USD |
150 +0.0% | 7,45 | 1 118 USD | |
2022-11-29 | 2022-11-29 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
150
+0.0%
7,451 118 USD |
150 +0.0% | 7,45 | 1 118 USD | |
2022-11-29 | 2022-11-28 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
150
+0.0%
7,401 110 USD |
150 +0.0% | 7,40 | 1 110 USD | |
2022-11-29 | 2022-11-25 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
150
+0.0%
7,381 107 USD |
150 +0.0% | 7,38 | 1 107 USD | |
2022-11-21 | 2022-11-18 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
7,233 615 USD |
500 +0.0% | 7,23 | 3 615 USD | |
2022-11-21 | 2022-11-17 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
250
+0.0%
7,241 810 USD |
250 +0.0% | 7,24 | 1 810 USD | |
2022-11-16 | 2022-11-10 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
7,077 070 USD |
1 000 +0.0% | 7,07 | 7 070 USD | |
2022-10-03 | 2022-09-30 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
7,463 730 USD |
500 +0.0% | 7,46 | 3 730 USD | |
2022-10-03 | 2022-09-28 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
7,233 615 USD |
500 +0.0% | 7,23 | 3 615 USD | |
2022-09-27 | 2022-09-26 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
7,693 845 USD |
500 +0.0% | 7,69 | 3 845 USD | |
2022-09-27 | 2022-09-23 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
7,937 930 USD |
1 000 +0.0% | 7,93 | 7 930 USD | |
2022-09-06 | 2022-09-02 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 200
+0.0%
8,3710 044 USD |
1 200 +0.0% | 8,37 | 10 044 USD | |
2022-09-06 | 2022-09-01 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
8,114 055 USD |
500 +0.0% | 8,11 | 4 055 USD | |
2022-08-30 | 2022-08-29 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
9,079 070 USD |
1 000 +0.0% | 9,07 | 9 070 USD | |
2022-08-22 | 2022-08-19 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
5 000
+0.2%
8,9944 950 USD |
5 000 +0.2% | 8,99 | 44 950 USD | |
2022-08-22 | 2022-08-18 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
14 426
+0.5%
8,58123 775 USD |
14 426 +0.5% | 8,58 | 123 775 USD | |
2022-08-16 | 2022-08-11 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
19 669
+0.7%
8,40165 220 USD |
19 669 +0.7% | 8,40 | 165 220 USD | |
2022-07-05 | 2022-06-30 |
Beyond Air Inc
(XAIR)
|
V Vente |
40 000
-21.9%
6,53261 104 USD |
40 000 -21.9% | 6,53 | 261 104 USD | |
2022-06-27 | 2022-06-24 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
400
+0.0%
12,184 872 USD |
400 +0.0% | 12,18 | 4 872 USD | |
2022-06-27 | 2022-06-23 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200
+0.0%
11,402 280 USD |
200 +0.0% | 11,40 | 2 280 USD | |
2022-06-27 | 2022-06-22 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
100
+0.0%
13,101 310 USD |
100 +0.0% | 13,10 | 1 310 USD | |
2022-05-31 | 2022-05-27 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
15,747 870 USD |
500 +0.0% | 15,74 | 7 870 USD | |
2022-05-31 | 2022-05-26 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
500
+0.0%
15,907 950 USD |
500 +0.0% | 15,90 | 7 950 USD | |
2022-05-23 | 2022-05-20 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
16,2816 280 USD |
1 000 +0.0% | 16,28 | 16 280 USD | |
2022-05-23 | 2022-05-19 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200
+0.0%
18,953 790 USD |
200 +0.0% | 18,95 | 3 790 USD | |
2022-05-19 | 2022-05-18 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
18,4918 490 USD |
1 000 +0.0% | 18,49 | 18 490 USD | |
2022-05-19 | 2022-05-18 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
700
+0.0%
20,6014 420 USD |
700 +0.0% | 20,60 | 14 420 USD | |
2022-05-19 | 2022-05-17 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
110
+0.0%
20,832 291 USD |
110 +0.0% | 20,83 | 2 291 USD | |
2022-05-19 | 2022-05-17 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200
+0.0%
19,773 954 USD |
200 +0.0% | 19,77 | 3 954 USD | |
2022-05-17 | 2022-05-16 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 000
+0.0%
19,3219 320 USD |
1 000 +0.0% | 19,32 | 19 320 USD | |
2022-05-17 | 2022-05-13 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
700
+0.0%
18,1012 670 USD |
700 +0.0% | 18,10 | 12 670 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
10 545
+0.4%
17,26182 007 USD |
10 545 +0.4% | 17,26 | 182 007 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
600
+0.0%
16,129 672 USD |
600 +0.0% | 16,12 | 9 672 USD | |
2022-05-13 | 2022-05-12 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
1 100
+0.0%
14,8816 368 USD |
1 100 +0.0% | 14,88 | 16 368 USD | |
2022-03-29 | 2022-03-28 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
4 000
+0.1%
7,0528 200 USD |
4 000 +0.1% | 7,05 | 28 200 USD | |
2022-03-18 | 2022-03-17 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
7 000
+0.2%
7,6353 410 USD |
7 000 +0.2% | 7,63 | 53 410 USD | |
2022-02-15 | 2022-02-14 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
8 000
+0.3%
5,8847 040 USD |
8 000 +0.3% | 5,88 | 47 040 USD | |
2022-02-11 | 2022-02-10 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
8 500
+0.3%
6,3453 890 USD |
8 500 +0.3% | 6,34 | 53 890 USD | |
2022-02-08 | 2022-02-07 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
6 000
+0.2%
8,2549 500 USD |
6 000 +0.2% | 8,25 | 49 500 USD | |
2022-02-08 | 2022-02-07 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
14 000
+0.5%
3,9355 020 USD |
14 000 +0.5% | 3,93 | 55 020 USD | |
2022-02-08 | 2022-02-04 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
12 500
+0.5%
3,8948 625 USD |
12 500 +0.5% | 3,89 | 48 625 USD | |
2022-02-08 | 2022-02-04 |
Nuvectis Pharma Inc
(NVCT)
|
A Achat |
200 000
+7.8%
5,001 000 000 USD |
200 000 +7.8% | 5,00 | 1 000 000 USD | |
2021-11-26 | 2021-11-24 |
Beyond Air Inc
(XAIR)
|
V Vente |
6 464
-3.4%
13,9990 431 USD |
6 464 -3.4% | 13,99 | 90 431 USD | |
2021-11-26 | 2021-11-24 |
Beyond Air Inc
(XAIR)
|
V Vente |
31 000
-14.1%
13,44416 640 USD |
31 000 -14.1% | 13,44 | 416 640 USD | |
2021-02-18 | 2021-02-12 |
Beyond Air Inc
(XAIR)
|
V Vente |
23 419
-11.4%
6,36148 945 USD |
23 419 -11.4% | 6,36 | 148 945 USD | |
2021-02-18 | 2021-02-11 |
Beyond Air Inc
(XAIR)
|
V Vente |
1 500
-0.8%
6,289 420 USD |
1 500 -0.8% | 6,28 | 9 420 USD | |
2021-02-08 | 2021-01-02 |
Beyond Air Inc
(XAIR)
|
V Vente |
5 700
-3.0%
5,8933 573 USD |
5 700 -3.0% | 5,89 | 33 573 USD | |
2020-08-27 | 2020-08-25 |
Beyond Air Inc
(XAIR)
|
VP Vente planifiée |
1 580
-0.8%
5,959 406 USD |
1 580 -0.8% | 5,95 | 9 406 USD | |
2020-08-25 | 2020-08-24 |
Beyond Air Inc
(XAIR)
|
VP Vente planifiée |
3 889
-2.0%
5,6822 104 USD |
3 889 -2.0% | 5,68 | 22 104 USD | |
2020-08-25 | 2020-08-21 |
Beyond Air Inc
(XAIR)
|
VP Vente planifiée |
3 246
-1.6%
6,0519 651 USD |
3 246 -1.6% | 6,05 | 19 651 USD | |
2020-08-21 | 2020-08-20 |
Beyond Air Inc
(XAIR)
|
VP Vente planifiée |
3 778
-1.9%
6,2923 780 USD |
3 778 -1.9% | 6,29 | 23 780 USD |